吉贝尔跌2.00%,成交额3994.42万元,主力资金净流出207.11万元

Core Viewpoint - The stock of Jibeier has experienced fluctuations, with a recent decline of 2.00% and a total market value of 5.863 billion yuan, reflecting mixed investor sentiment and trading activity [1]. Group 1: Stock Performance - As of January 15, Jibeier's stock price is 29.40 yuan per share, with a trading volume of 39.944 million yuan and a turnover rate of 0.67% [1]. - Year-to-date, the stock has decreased by 1.51%, with a 3.29% drop over the last five trading days, a 4.11% increase over the last 20 days, and a 9.48% decline over the last 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, Jibeier reported a revenue of 704 million yuan, representing a year-on-year growth of 9.52%, and a net profit attributable to shareholders of 197 million yuan, up by 12.80% [2]. Group 3: Shareholder Information - As of January 9, 2025, Jibeier has 7,406 shareholders, an increase of 3.35% from the previous period, with an average of 26,928 circulating shares per shareholder, a decrease of 3.24% [2]. - Since its A-share listing, Jibeier has distributed a total of 476 million yuan in dividends, with 252 million yuan distributed over the last three years [3]. - Notable new institutional shareholders include Caitong Advantage Industry Rotation Mixed A (011201) and GF Healthcare Stock A (004851), holding 1.2392 million shares and 959,000 shares respectively [3].

Jiangsu Jibeier Pharmaceutical -吉贝尔跌2.00%,成交额3994.42万元,主力资金净流出207.11万元 - Reportify